| Vorinostat | IC50 | 122.0 [1] |
| Vorinostat | Ki | 2470.0 [1] |
| Trichostatin A | IC50 | 15.0 [1] |
| Trichostatin A | Ki | 504.0 [1] |
| Entinostat | IC50 | 3200.0 [1] |
| CID 71520717 | IC50 | 360.0 [1] |
| N-[6-(Hydroxyamino)-6-oxohexoxy]-3-methylbenzamide | IC50 | 1130.0 [1] |
| N-[6-(Hydroxyamino)-6-oxohexoxy]-3,4-dimethylbenzamide | IC50 | 1100.0 [1] |
| Apicidin | IC50 | 1.0 [1] |
| 7-Mercapto-heptanoic acid phenylamide | IC50 | 58.0 [1], 210.0 [2] |
| Sodium | IC50 | 140000.0 [1], 800000.0 [2] |
| Sodium | Ki | 6340.0 [1] |
| Romidepsin | IC50 | 3.6 [1], 15.0 [2], 107.2 [3], 250.0 [4] |
| Dacinostat | IC50 | 32.0 [1], 50.0 [2] |
| Cudc-101 | IC50 | 4.4 [1], 464.0 [2], 602.0 [3] |
| N1-(2-Aminophenyl)-N8-phenyloctanediamide | IC50 | 87000.0 [1], 120000.0 [2] |
| 4-(Dimethylamino)-N-[6-(hydroxyamino)-6-oxohexyl]-benzamide | IC50 | 110.0 [1], 152.0 [2], 244.0 [3], 1866.0 [4] |
| Chlorogenic acid | IC50 | 200000.0 [1], 375000.0 [2] |
| Belinostat | IC50 | 26.4 [1], 27.0 [2], 28.0 [3] |
| Trapoxin B | IC50 | 4.0 [1], 5.0 [2] |
| 6-(2-Mercaptoacetylamino)-N-Phenylhexanamide | IC50 | 390.0 [1], 2440.0 [2] |
| 1,1,1-Trifluoro-8-(4-biphenylyloxy)-2-octanone | IC50 | 2900.0 [1] |
| 8-Mercapto-octanoic acid phenylamide | IC50 | 1500.0 [1] |
| 7-(Benzoylamino)heptanehydroxamic acid | IC50 | 568.0 [1], 1006.0 [2], 10000.0 [3] |
| N-Quinolin-3-yl-7-sulfanylheptanamide | IC50 | 72.0 [1] |
| S-(7-Anilino-7-oxoheptyl) ethanethioate | IC50 | 7100.0 [1] |
| 6-Mercapto-hexanoic acid phenylamide | IC50 | 370.0 [1] |
| (E)-N-Hydroxy-3-[4-[(3-phenylpropylamino)methyl]phenyl]prop-2-enamide | IC50 | 64.0 [1], 150.0 [2] |
| N-(6-Sulfanylhexyl)-1-benzofuran-2-carboxamide | IC50 | 79.0 [1] |
| 6-(2-Hydroxyacetamido)-N-phenylhexanamide | IC50 | 40000.0 [1], 100000.0 [2] |
| Thioacetic acid S-[(5-phenylcarbamoyl-pentylcarbamoyl)-methyl] ester | IC50 | 20100.0 [1], 22000.0 [2] |
| 7-Methylsulfanyl-heptanoic acid phenylamide | IC50 | 100000.0 [1] |
| 5-Mercapto-pentanoic acid phenylamide | IC50 | 6200.0 [1] |
| 4-(6-Anilino-6-oxohexyl)semicarbazide | IC50 | 150000.0 [1] |
| 6-[4-[(4-Chlorophenyl)sulfonylamino]phenyl]sulfanyl-N-hydroxyhexanamide | IC50 | 110.0 [1], 9400.0 [2] |
| 7-(4-Chlorophenyl)sulfinyl-N-hydroxyheptanamide | IC50 | 380.0 [1], 1600.0 [2] |
| 6-(4-Chlorophenyl)sulfinyl-N-hydroxyhexanamide | IC50 | 150.0 [1], 1300.0 [2] |
| 6-[4-(Dimethylamino)phenyl]sulfinyl-N-hydroxyhexanamide | IC50 | 180.0 [1], 2200.0 [2], 2240.0 [3] |
| 6-Benzenesulfonylhexanoic acid hydroxamide | IC50 | 40.0 [1], 15500.0 [2] |
| 6-Phenylsulfanylhexanoic acid hydroxamide | IC50 | 120.0 [1], 9400.0 [2] |
| 6-(Benzenesulfinyl)hexanoic acid hydroxyamide | IC50 | 60.0 [1], 7400.0 [2], 7700.0 [3] |
| Ethyl 2-(4-methoxyphenyl)-2-oxoethyl trithiocarbonate | IC50 | 375.0 [1], 501.19 [2], 4670.0 [3] |
| N-[4-(2-Ethylsulfanylcarbothioylsulfanylacetyl)phenyl]acetamide | IC50 | 318.0 [1], 398.11 [2], 857.0 [3] |
| N-[3-(2-Ethylsulfanylcarbothioylsulfanylacetyl)phenyl]acetamide | IC50 | 506.0 [1], 630.96 [2], 3280.0 [3] |
| N-[4-(2-Ethylsulfanylcarbothioylsulfanylacetyl)phenyl]methanesulfonamide | IC50 | 1260.0 [1], 1995.26 [2], 8950.0 [3] |
| Ethyl 2-(4-methylphenyl)-2-oxoethyl trithiocarbonate | IC50 | 375.0 [1], 630.96 [2], 812.0 [3] |
| 6-(4-Chlorophenyl)sulfanyl-N-hydroxyhexanamide | IC50 | 260.0 [1], 25000.0 [2] |
| N-[2-[[4-[(1-Benzylpiperidin-4-yl)amino]-7-methoxyquinazolin-2-yl]amino]ethyl]-N'-hydroxyoctanediamide | IC50 | 15330.0 [1], 27750.0 [2], 100000.0 [3] |
| N'-Hydroxy-N-[2-[[7-methoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-yl]amino]ethyl]octanediamide | IC50 | 100000.0 [1] |
| N-[2-[[4-[(1-Benzylpiperidin-4-yl)amino]-7-methoxyquinazolin-2-yl]amino]ethyl]-N'-hydroxyheptanediamide | IC50 | 5735.0 [1], 13800.0 [2], 100000.0 [3] |
| Valproic acid | IC50 | 995000.0 [1], 7240000.0 [2] |
| Erlotinib | IC50 | 15800.0 [1], 32000.0 [2] |
| 4-(Dimethylamino)-n-[7-(hydroxyamino)-7-oxoheptyl]benzamide | IC50 | 46.0 [1], 1620.0 [2] |
| Harmine | IC50 | 10000.0 [1] |
| Vandetanib | IC50 | 10000.0 [1] |
| Panobinostat | IC50 | 0.83 [1], 30.0 [2] |
| 3,5-Dicaffeoylquinic acid | IC50 | 143240.0 [1], 500000.0 [2] |
| Neochlorogenic acid | IC50 | 170400.0 [1], 200000.0 [2] |
| Tacedinaline | IC50 | 2590.0 [1], 6000.0 [2] |
| Methyl 3,5-di-O-caffeoyl quinate | IC50 | 4990.0 [1], 7590.0 [2] |
| 5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione | IC50 | 450.0 [1] |
| Pyroxamide | IC50 | 200.0 [1], 10000.0 [2] |
| 4-(Dimethylamino)-N-[[4-[(E)-3-(hydroxyamino)-3-oxoprop-1-enyl]phenyl]methyl]benzamide | IC50 | 172.0 [1], 172.02 [2] |
| 4-Acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | IC50 | 204.0 [1], 300.0 [2] |
| (E)-5-[4-(Benzenesulfonamido)phenyl]-N-hydroxypent-2-en-4-ynamide | IC50 | 233.15 [1], 2000.0 [2] |
| 9,9,9-Trifluoro-8-Oxo-N-Phenylnonanamide | IC50 | 6700.0 [1] |
| N-Hydroxy-2,2-diphenylacetamide | IC50 | 4600.0 [1], 50000.0 [2] |
| N-Hydroxy-4-(4-phenylbutanoylamino)benzamide | IC50 | 44.0 [1] |
| N-Hydroxy-3-[6-oxo-1-(2-phenylethyl)-2,3-dihydropyridin-5-yl]propanamide | IC50 | 350.0 [1] |
| CID 11427204 | IC50 | 170.0 [1] |
| N1-(4-(3-Aminophenyl)thiazol-2-yl)-N8-hydroxyoctanediamide | IC50 | 3.9 [1], 8.0 [2] |
| 8-[4-(Dimethylamino)benzoylamino]octanehydroxamic acid | IC50 | 145.0 [1], 2180.0 [2] |
| N-Methyl-2-oxo-8-(4-phenylphenoxy)octanamide | IC50 | 110.0 [1] |
| N-[[4-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]phenyl]methyl]-4-pyrrolidin-1-ylbenzamide | IC50 | 205.0 [1], 205.27 [2] |
| 6-(4-Phenylbenzoylamino)hexanehydroxamic acid | IC50 | 38.0 [1], 265.0 [2] |
| N1-Hydroxy-N8-(4-phenylthiazol-2-yl)octanediamide | IC50 | 6.6 [1], 15.0 [2] |
| 3-(1-Benzyl-6-oxo-2,3-dihydropyridin-5-yl)-N-hydroxypropanamide | IC50 | 670.0 [1] |
| 6-Phenoxyhexane-1-thiol | IC50 | 11000.0 [1] |
| N-(3-Phenylphenyl)-7-sulfanylheptanamide | IC50 | 75.0 [1] |
| Tucidinostat | IC50 | 7160.0 [1], 7200.0 [2] |
| (E)-N-Hydroxy-3-[4-(4-methoxyphenyl)phenyl]prop-2-enamide | IC50 | 8700.0 [1], 32600.0 [2] |
| N-Hydroxy-6-[(2S,5S,8S,11S)-8-(1H-indol-3-ylmethyl)-2-methyl-11-(2-methylpropyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanamide | IC50 | 1.0 [1], 3.0 [2] |
| 6-[(2S,5S,8S,11S)-2-Methyl-11-(2-methylpropyl)-8-(naphthalen-1-ylmethyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanoic acid | IC50 | 205.0 [1], 377.0 [2] |
| N-Hydroxy-9H-xanthene-9-carboxamide | IC50 | 3000.0 [1], 50000.0 [2] |
| N-Hydroxy-6-(naphthalen-1-ylcarbamoylamino)oxyhexanamide | IC50 | 900.0 [1], 1060.0 [2] |
| 1-(4-Tert-butylphenyl)-3-[6-(hydroxyamino)-6-oxo-hexoxy]urea | IC50 | 1320.0 [1], 1410.0 [2] |
| Octanedioic acid phenylamide pyridin-2-ylamide | IC50 | 99000.0 [1], 100000.0 [2] |
| (E)-N-Hydroxy-3-(4-{[2-(1H-indol-3-yl)-ethylamino]-methyl}-phenyl)-acrylamide | IC50 | 63.0 [1] |
| Pyridin-3-ylmethyl N-[[4-[(2-amino-5-methoxyphenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 4600.0 [1] |
| 7-[(2-Bromoacetyl)amino]-N-phenylheptanamide | IC50 | 14000.0 [1] |
| Pyridin-3-ylmethyl N-[[4-[(2-hydroxyphenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 2200.0 [1] |
| N-Hydroxy-6-[[(2S)-2-[(3R,4R)-3-(2-methylpropyl)-2,5-dioxo-4-propylpyrrolidin-1-yl]-3-phenylpropanoyl]amino]hexanamide | IC50 | 51.0 [1] |
| Pyridin-3-ylmethyl N-[[4-[(2-acetamidophenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 100000.0 [1] |
| Pyridin-3-ylmethyl N-[[4-[(2-amino-4-methylphenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 100000.0 [1] |
| Pyridin-3-ylmethyl N-[[4-[(2-amino-4-chlorophenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 40000.0 [1] |
| (3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-(1-methoxy-4-oxoquinolin-3-yl)-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone | IC50 | 86.0 [1] |
| Pyridin-3-ylmethyl N-[[4-[(4-aminophenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 100000.0 [1] |
| Pyridin-3-ylmethyl N-[[4-[(2-amino-4-methoxyphenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 44000.0 [1] |
| (3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-(1-ethyl-4-oxoquinolin-3-yl)-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone | IC50 | 330.0 [1] |
| Pyridin-3-ylmethyl N-[[4-[(3-aminophenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 100000.0 [1] |